Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
EXT2 gene
Introduction
Exostosin-2 is a protein that in humans is encoded by the EXT2 gene.[1][2][3]
This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of Multiple Exostoses.[3]
References
References
- ↑ Wu YQ, Heutink P, de Vries BB, Sandkuijl LA, van den Ouweland AM, Niermeijer MF, Galjaard H, Reyniers E, Willems PJ, Halley DJ (May 1994). “Assignment of a second locus for multiple exostoses to the pericentromeric region of chromosome 11”. Hum Mol Genet. 3 (1): 167–71. doi:10.1093/hmg/3.1.167. PMID 8162019.
- ↑ Bridge JA, Nelson M, Orndal C, Bhatia P, Neff JR (May 1998). “Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas”. Cancer. 82 (9): 1657–63. doi:10.1002/(SICI)1097-0142(19980501)82:9<1657::AID-CNCR10>3.0.CO;2-3. PMID 9576285.
- ↑ 3.0 3.1 “Entrez Gene: EXT2 exostoses (multiple) 2”.
- ↑ Simmons, A D; Musy M M; Lopes C S; Hwang L Y; Yang Y P; Lovett M (Nov 1999). “A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses”. Hum. Mol. Genet. ENGLAND. 8 (12): 2155–64. doi:10.1093/hmg/8.12.2155. ISSN 0964-6906. PMID 10545594.
Further reading
Further reading
- Wuyts W, Van Hul W (2000). “Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2 genes”. Hum. Mutat. 15 (3): 220–7. doi:10.1002/(SICI)1098-1004(200003)15:3<220::AID-HUMU2>3.0.CO;2-K. PMID 10679937.
- Wuyts W, Ramlakhan S, Van Hul W, et al. (1995). “Refinement of the Multiple Exostoses Locus (EXT2) to a 3-cM Interval on Chromosome 11”. Am. J. Hum. Genet. 57 (2): 382–7. PMC 1801560. PMID 7668264.
- Stickens D, Clines G, Burbee D, et al. (1996). “The EXT2 multiple exostoses gene defines a family of putative tumour suppressor genes”. Nat. Genet. 14 (1): 25–32. doi:10.1038/ng0996-25. PMID 8782816.
- Wuyts W, Van Hul W, Wauters J, et al. (1997). “Positional cloning of a gene involved in hereditary multiple exostoses”. Hum. Mol. Genet. 5 (10): 1547–57. doi:10.1093/hmg/5.10.1547. PMID 8894688.
- Clines GA, Ashley JA, Shah S, Lovett M (1997). “The Structure of the Human Multiple Exostoses 2 Gene and Characterization of Homologs in Mouse and Caenorhabditis elegans”. Genome Res. 7 (4): 359–67. doi:10.1101/gr.7.4.359. PMC 139145. PMID 9110175.
- Philippe C, Porter DE, Emerton ME, et al. (1997). “Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses”. Am. J. Hum. Genet. 61 (3): 520–8. doi:10.1086/515505. PMC 1715939. PMID 9326317.
- Wuyts W, Van Hul W, De Boulle K, et al. (1998). “Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses”. Am. J. Hum. Genet. 62 (2): 346–54. doi:10.1086/301726. PMC 1376901. PMID 9463333.
- McCormick C, Leduc Y, Martindale D, et al. (1998). “The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate”. Nat. Genet. 19 (2): 158–61. doi:10.1038/514. PMID 9620772.
- Lind T, Tufaro F, McCormick C, et al. (1998). “The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate”. J. Biol. Chem. 273 (41): 26265–8. doi:10.1074/jbc.273.41.26265. PMID 9756849.
- Park KJ, Shin KH, Ku JL, et al. (1999). “Germline mutations in the EXT1 and EXT2 genes in Korean patients with hereditary multiple exostoses”. J. Hum. Genet. 44 (4): 230–4. doi:10.1007/s100380050149. PMID 10429361.
- Xu L, Xia J, Jiang H, et al. (1999). “Mutation analysis of hereditary multiple exostoses in the Chinese”. Hum. Genet. 105 (1–2): 45–50. doi:10.1007/s004390051062. PMID 10480354.
- Simmons AD, Musy MM, Lopes CS, et al. (1999). “A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses”. Hum. Mol. Genet. 8 (12): 2155–64. doi:10.1093/hmg/8.12.2155. PMID 10545594.
- McCormick C, Duncan G, Goutsos KT, Tufaro F (2000). “The putative tumor suppressors EXT1 and EXT2 form a stable complex that accumulates in the Golgi apparatus and catalyzes the synthesis of heparan sulfate”. Proc. Natl. Acad. Sci. U.S.A. 97 (2): 668–73. Bibcode:2000PNAS…97..668M. doi:10.1073/pnas.97.2.668. PMC 15388. PMID 10639137.
- Kobayashi S, Morimoto K, Shimizu T, et al. (2000). “Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus”. Biochem. Biophys. Res. Commun. 268 (3): 860–7. doi:10.1006/bbrc.2000.2219. PMID 10679296.
- Shi YR, Wu JY, Tsai FJ, et al. (2000). “An R223P mutation in EXT2 gene causes hereditary multiple exostoses”. Hum. Mutat. 15 (4): 390–1. doi:10.1002/(SICI)1098-1004(200004)15:4<390::AID-HUMU35>3.0.CO;2-E. PMID 10738008.
- Stickens D, Brown D, Evans GA (2000). “EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis”. Dev. Dyn. 218 (3): 452–64. doi:10.1002/1097-0177(200007)218:3<452::AID-DVDY1000>3.0.CO;2-P. PMID 10878610.
- Bernard MA, Hall CE, Hogue DA, et al. (2001). “Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2 in exostosis chondrocytes”. Cell Motil. Cytoskeleton. 48 (2): 149–62. doi:10.1002/1097-0169(200102)48:2<149::AID-CM1005>3.0.CO;2-3. PMID 11169766.